Curaleaf (OTCMKTS:CURLF) Shares Gap Down – What’s Next?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares gapped down prior to trading on Wednesday . The stock had previously closed at $2.72, but opened at $2.62. Curaleaf shares last traded at $2.6680, with a volume of 14,037 shares changing hands.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CURLF. Zacks Research raised shares of Curaleaf from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. ATB Capital raised shares of Curaleaf to an “outperform” rating in a report on Tuesday, December 2nd. Alliance Global Partners reaffirmed a “buy” rating on shares of Curaleaf in a report on Monday, December 22nd. Atb Cap Markets upgraded shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 2nd. Finally, Canaccord Genuity Group upgraded Curaleaf to a “strong-buy” rating in a report on Thursday, October 9th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy”.

Curaleaf Stock Up 1.4%

The company has a debt-to-equity ratio of 0.96, a current ratio of 1.47 and a quick ratio of 0.71. The firm’s 50-day moving average price is $2.66 and its 200 day moving average price is $2.45. The firm has a market capitalization of $1.81 billion, a price-to-earnings ratio of -8.34 and a beta of 0.73.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Wednesday, November 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative return on equity of 15.57% and a negative net margin of 19.50%. Sell-side analysts expect that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.